Duquesne Family Office's billionaire chief sold every share of Wall Street's hottest artificial intelligence (AI) stock in favor of a drugmaker whose shares have surged 142% in two years.

UroGen Pharma shares rallied to a three-month high after the FDA approved Zusduri, a non-surgical treatment for a type of bladder cancer.

Natco Pharma shares slipped in trade after the company said that the USFDA has issued one (1) observation in the Form-483 for ...

Indian benchmark indices, Nifty and Sensex, are expected to see a positive start on Monday as indicated by the Gift Nifty.

Gujarat Themis Biosyn, Godrej Properties, Sun Pharmaceutical Industries, Belrise Industries, Syngene International, Natco ...

Shares to fall as Middle East tensions escalate; oil spikes above $US78.32; gold climbs. ASIC investigate ASX; Adnoc agrees ...

Known from Reese's and its namesake brand, Hershey has two multi-billion chocolate power brands generating about half of ...

Britain faces paying more for US drugs as part of a deal to avoid future tariffs from Donald Trump. The NHS will review drug ...

Social media is filled with warnings that grocers will use the tech to charge more for ice cream if it’s hot out or hike the price of umbrellas if it’s raining.

Here's a look at how much you might save on your prescriptions if you bought them directly from celeb billionaire Mark ...

AbbVie combines high yield, strong growth from Rinvoq and Skyrizi, and a solid pipeline to support dividends and returns.